OrigiMed Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 17

OrigiMed General Information

Description

Developer and researcher of new technologies and clinical application for cancer patients. The company conducts more comprehensive high-throughput methods and leverage extensive bioinformatics analysis and clinical annotation to identify cancer specific molecular markers and genomic features to guide immuno-therapy, providing clinical advancements in the field of precision medicine for cancer.

Contact Information

Website
www.origimed.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building 3, No. 115, Xinjunhuan Road
  • Minhang District
  • Shanghai
  • China
+86 400
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 5th Floor, Building 3, No. 115, Xinjunhuan Road
  • Minhang District
  • Shanghai
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OrigiMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 05-May-2023 Completed Generating Revenue
6. Later Stage VC 12-Nov-2021 Completed Generating Revenue
5. Later Stage VC (Series C) 28-Jun-2021 Completed Generating Revenue
4. Early Stage VC (Series B1) 23-Nov-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 24-Dec-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 20-Dec-2017 Completed Generating Revenue
1. Seed Round 20-Sep-2016 Completed Startup
To view OrigiMed’s complete valuation and funding history, request access »

OrigiMed Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jinding Capital Venture Capital Minority
Jingming Innovation Capital Venture Capital Minority
Haitong Fortis Private Equity Growth/Expansion Minority
Orient Securities Company Limited Partner Minority
Ping An Capital PE/Buyout Minority
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

OrigiMed FAQs

  • When was OrigiMed founded?

    OrigiMed was founded in 2016.

  • Where is OrigiMed headquartered?

    OrigiMed is headquartered in Shanghai, China.

  • What industry is OrigiMed in?

    OrigiMed’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is OrigiMed a private or public company?

    OrigiMed is a Private company.

  • What is OrigiMed’s current revenue?

    The current revenue for OrigiMed is .

  • Who are OrigiMed’s investors?

    Jinding Capital, Jingming Innovation Capital, Haitong Fortis Private Equity, Orient Securities Company, and Ping An Capital are 5 of 17 investors who have invested in OrigiMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process